Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

6.85

-0.33 (-4.60%)

At close: Mar 13, 2026, 4:00 PM EDT

7.08

+0.23 (3.36%)

After-hours: Mar 13, 2026, 4:48 PM EDT

Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	38.94	41.75	35.49	40.46	62.88	21.23
Short-Term Investments	51.2	90.5	165.88	236.11	145.47	119.22
Cash & Short-Term Investments	90.14	132.25	201.37	276.56	208.36	140.45
Cash Growth	-39.26%	-34.33%	-27.19%	32.73%	48.35%	79.59%
Other Current Assets	4.27	5.24	5.58	9.16	3.3	4.36
Total Current Assets	94.4	137.49	206.95	285.72	211.65	144.81
Net Property, Plant & Equipment	3.23	4.78	8.69	13.17	6	6.75
Other Long-Term Assets	-	2.42	5.6	0.67	0.28	0.28
Total Assets	97.73	144.68	221.24	299.57	217.93	151.84
Accounts Payable	0.91	3.65	8.25	2.48	2.03	2.36
Accrued Expenses	3.93	7.94	6.48	5.95	4.99	3.02
Short-Term Debt	5.28	5.22	-	-	-	-
Current Portion of Leases	3.26	3.53	3.01	2.57	1.2	1.04
Other Current Liabilities	3.93	7.94	6.48	5.95	4.99	3.04
Total Current Liabilities	13.38	20.33	17.74	11	8.21	6.44
Long-Term Debt	1.37	5.11	10.07	9.83	9.62	-
Long-Term Leases	-	2.33	5.85	8.87	3.22	4.42
Total Long-Term Liabilities	1.37	7.44	15.92	18.7	12.85	4.42
Total Liabilities	14.75	27.77	33.67	29.7	21.06	10.86
Common Stock	0.01	0.01	0.01	0.07	0.06	0.05
Additional Paid-in Capital	558.94	551.57	538.46	519.62	377.77	267.09
Accumulated Other Comprehensive Income	0.01	-0.16	-0.13	-0.92	-0.29	-0.14
Retained Earnings	-475.99	-434.49	-350.76	-248.89	-180.65	-126.02
Shareholders' Equity	82.98	116.92	187.57	269.87	196.88	140.98
Total Liabilities & Equity	97.73	144.68	221.24	299.57	217.93	151.84
Total Debt	9.91	16.18	18.93	21.26	14.04	5.46
Net Cash (Debt)	80.22	116.07	182.44	255.3	194.31	134.98
Net Cash Growth	-30.88%	-36.38%	-28.54%	31.39%	43.95%	87.89%
Net Cash Per Share	10.97	15.92	25.14	37.90	36.83	30.68
Book Value	82.98	116.92	187.57	269.87	196.88	140.98
Book Value Per Share	11.35	16.04	25.85	40.06	37.32	32.04
Tangible Book Value	82.98	116.92	187.57	269.87	196.88	140.98
Tangible Book Value Per Share	11.35	16.04	25.85	40.06	37.32	32.04

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q